“Unusual” symptoms in person who died in Denmark after injection of AstraZeneca vaccine
Posted On March 15, 2021
Denmark suspended on Thursday, as a precaution, the use of the Anglo-Swedish company’s vaccine against Covid-19 due to fears related to the formation of blood clots in some vaccinated people.
Cases of thrombosis have also been reported in Norway, prompting the country to suspend use of the AstraZeneca vaccine. Several European countries such as Ireland, Iceland and the Netherlands then followed suit with the two Nordic countries. In Italy, the Piedmont region (northeast of Italy) announced on Sunday that it had resumed AstraZeneca vaccinations, however excluding as a precaution a batch, after the death of a teacher vaccinated the day before.
For its part, the European Medicines Agency (EMA) opened an “accelerated” investigation but continues to advocate the use of the product, stressing that the benefits continued to outweigh the risks.
Thirty cases of thromboembolic incidents have been reported on some five million people vaccinated within the European Economic Area (EEA), according to Professor Jean-Michel Dogné of the Vaccination task force in Belgium. The latter also shares the reasoning of the EMA on the “positive balance” of the AstraZeneca vaccine.
The Anglo-Swedish pharmaceutical group says for its part that there is “no evidence of an increased risk” of a blood clot caused by its vaccine, while the World Health Organization (WHO) believes that it does not There is “no reason not to use” this vaccine.
In total, nearly ten countries have suspended the use of the AstraZeneca vaccine against Covid-19 as a precaution, after the reporting of “possible” side effects but without a proven link at this stage.